Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye. The study demonstrated for the ...
July 17 (Reuters) - Essex Bio-Technology Ltd: * UNIT GETS APPROVAL FROM STATE DRUG ADMINISTRATION FOR COMMERCIALISATION OF SINGLE-DOSE LEVOFLOXACIN EYE DROPS IN CHINA Source text for Eikon: Further ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...